YAP1 and cancer: The pancancer analysis also uncovered YAP1 gene amplification in squamous cell, cervical, lung, esophageal, head and neck, and bladder urothelial carcinomas, suggesting that these cancers might also benefit from TEAD inhibitor treatment [18,187].